- Home
- ENTX vs ECBK Comparison
ENTX vs ECBK Comparison
Compare ENTX & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENTX | ECBK |
|---|---|---|
| Founded | 2010 | 1919 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 153.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENTX | ECBK |
|---|---|---|
| Price | $1.62 | $17.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 305.4K | 9.3K |
| Earning Date | 11-14-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.95 |
| EPS | N/A | ★ 0.80 |
| Revenue | $124,000.00 | ★ $29,860,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.49 |
| Revenue Growth | ★ 25.25 | 20.84 |
| 52 Week Low | $1.45 | $12.56 |
| 52 Week High | $3.22 | $17.75 |
Technical Indicators
Market Signals| Indicator | ENTX | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 56.39 |
| Support Level | $1.45 | $17.16 |
| Resistance Level | $1.80 | $17.39 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 30.51 | 68.21 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.